Magnesium reduces anxiety

Magnesium for anxiety has not really been tested. The trials that exist are small, every one of them recruited people already prone to anxiety or stress, and the two systematic reviews this claim cites both stop short of a conclusion. The larger review found 18 studies and reported that four of eight trials in anxious groups and four of seven in premenstrual groups showed a benefit, while describing the quality of that evidence as poor and calling for properly designed trials. A 2024 review screened 860 papers down to 15, of which seven measured anxiety, and found five of the seven reported an improvement in self-reported anxiety. Its authors qualify that heavily: doses, forms and durations differed across every study, participant numbers were small, and some tested products contained other active ingredients.

The single most-cited trial in this area had no placebo group. It gave 264 stressed adults with low blood magnesium either magnesium or magnesium plus vitamin B6, so every participant received magnesium. Both groups improved by roughly 43 percent over eight weeks. With no untreated comparison there is no way to separate the supplement from time, attention and expectation, and a drop that size over two months is consistent with either. The trial is widely cited as evidence that magnesium reduces stress. Its design cannot establish that.

Where a placebo group was used, the picture thins further. A 2022 double-blind placebo-controlled trial in 75 fibromyalgia patients missed its primary endpoint outright, with stress scores falling in both arms and no difference between them. Its positive result comes from an analysis the paper describes as post hoc, covering 16 of the 75 patients, roughly eight per arm. Blood and red-cell magnesium did not differ between the groups at the end of the trial, so magnesium status did not measurably change even in the patients who appeared to improve. A triple-blind placebo-controlled trial in 99 postpartum women found nothing on state anxiety, trait anxiety or depressive symptoms, and said so plainly.

Baseline status is the thread running through the positive results. Both reviews land in the same place, that the benefit shows up mainly in people who start with low magnesium, and the largest trial recruited only people with low blood magnesium to begin with. Both reviews also note that the two clearly negative anxiety trials were in postpartum and premenstrual groups, where other physiology is driving the symptoms. What has not been tested is whether magnesium reduces anxiety in someone who is not short of it.

The biology is better established than the clinical result. Magnesium blocks NMDA receptors, which quiet the brain's main excitatory signal, supports GABA activity, the main calming one, and acts on the HPA axis that runs the stress response. In mice, dietary magnesium deficiency reliably produces anxious behaviour alongside raised corticotropin-releasing hormone and ACTH, and that behaviour responds to standard anxiolytic and antidepressant drugs. That is a well-mapped pathway established in animals, and it is a reason a modest effect in deficient humans is plausible rather than evidence that one exists.

One reference point worth knowing. The NIH Office of Dietary Supplements fact sheet for health professionals on magnesium runs to about 50,000 characters covering blood pressure, type 2 diabetes, bone health and migraine, and does not mention anxiety anywhere in it. On dose and safety, that sheet sets the upper limit for supplemental magnesium at 350mg per day for adults, counted separately from magnesium in food, and documents interactions with oral bisphosphonates, tetracycline and quinolone antibiotics, along with effects on magnesium status from diuretics and proton pump inhibitors. The same sheet states that the risk of magnesium toxicity increases with impaired kidney function or kidney failure, because the body's ability to remove excess magnesium is reduced or lost. The Drug Facts label on over-the-counter magnesium citrate, sold as a saline laxative, tells users to ask a doctor before use if they have kidney disease or are on a magnesium-restricted diet, and to take it 2 or more hours before or after other drugs.